| Authors: |
Garcia-Saenz JA; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid, Spain. jgsaenz@salud.madrid.org., Lopez-Barajas IB; Hospital Universitario San Cecilio, Instituto de Investigación Biosanitaria de Granada (Ibs.Granada) and Medicine Department, Granada University, Granada, Spain., Echavarria I; Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), CIBERONC, Madrid, Spain., Gonzalez CH; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Vila MM; Institut Català d'Oncologia (ICO)-Badalona (Hospital Germans Trias I Pujol), B-ARGO (Badalona Applied Research Group in Oncology) and CARE (Translational Program in Cancer Research), Badalona, Spain., Antón FM; Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), CIBERONC, Madrid, Spain., Pernas S; Institut Català d'Oncologia (ICO)-L'Hospitalet, Institut d'Investigacio Biomedica de Bellvitge (IDIBELL), L'Hospitalet de Llobregat (Barcelona), Barcelona, Spain., Cajal TRY; Hospital de La Santa Creu I Sant Pau, Barcelona, Spain., Ribelles N; UGCI Oncología Intercentros, Hospitales Universitarios Regional y Virgen de La Victoria (IBIMA), Málaga, Spain., Ezquerra MB; Hospital Universitario Vall D'Hebron, and Vall d'Hebron Institue of Oncology (VHIO), Barcelona, Spain. |
